Hormonal influence: unraveling the impact of sex hormones on vascular smooth muscle cells.

Keran Jia, Xin Luo, Jingyan Yi, Chunxiang Zhang
Author Information
  1. Keran Jia: Department of Medical Cell Biology and Genetics, School of Basic Medical Sciences, Basic Medicine Research Innovation Center for Cardiometabolic Diseases, Ministry of Education, Southwest Medical University, Luzhou, Sichuan, 646000, China.
  2. Xin Luo: Department of Medical Cell Biology and Genetics, School of Basic Medical Sciences, Basic Medicine Research Innovation Center for Cardiometabolic Diseases, Ministry of Education, Southwest Medical University, Luzhou, Sichuan, 646000, China.
  3. Jingyan Yi: Department of Medical Cell Biology and Genetics, School of Basic Medical Sciences, Basic Medicine Research Innovation Center for Cardiometabolic Diseases, Ministry of Education, Southwest Medical University, Luzhou, Sichuan, 646000, China. jingyany@swmu.edu.cn. ORCID
  4. Chunxiang Zhang: Department of Cardiology, The Affiliated Hospital, Basic Medicine Research Innovation Center for Cardiometabolic Diseases, Ministry of Education, Southwest Medical University, Luzhou, Sichuan, 646000, China. zhangchx999@163.com.

Abstract

Sex hormones play a pivotal role as endocrine hormones that exert profound effects on the biological characteristics and vascular function of vascular smooth muscle cells (VSMCs). By modulating intracellular signaling pathways, activating nuclear receptors, and regulating gene expression, sex hormones intricately influence the morphology, function, and physiological state of VSMCs, thereby impacting the biological properties of vascular contraction, relaxation, and growth. Increasing evidence suggests that abnormal phenotypic changes in VSMCs contribute to the initiation of vascular diseases, including atherosclerosis. Therefore, understanding the factors governing phenotypic alterations in VSMCs and elucidating the underlying mechanisms can provide crucial insights for refining interventions targeted at vascular diseases. Additionally, the varying levels of different types of sex hormones in the human body, influenced by sex and age, may also affect the phenotypic conversion of VSMCs. This review aims to explore the influence of sex hormones on the phenotypic switching of VSMCs and the development of associated vascular diseases in the human body.

Keywords

References

  1. Cell Signal. 2020 Feb;66:109458 [PMID: 31678252]
  2. Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):2192-9 [PMID: 9351389]
  3. Clin Chim Acta. 2021 May;516:15-26 [PMID: 33476587]
  4. Mol Med Rep. 2017 Jun;15(6):3840-3846 [PMID: 28393190]
  5. Annu Rev Physiol. 2012;74:13-40 [PMID: 22017177]
  6. Stem Cells. 2007 Jun;25(6):1339-47 [PMID: 17379763]
  7. J Vasc Surg. 2011 Aug;54(2):341-5, 345.e1-2 [PMID: 21620618]
  8. Int J Cardiol. 1997 Dec 31;62 Suppl 2:S85-90 [PMID: 9488199]
  9. Int J Mol Sci. 2019 Jun 01;20(11): [PMID: 31159424]
  10. Front Physiol. 2021 Dec 07;12:762437 [PMID: 34950048]
  11. Atherosclerosis. 2015 Jun;240(2):453-61 [PMID: 25898000]
  12. Cell Biol Int. 2012 Feb;36(2):155-61 [PMID: 22032345]
  13. Wound Repair Regen. 2020 Jul;28(4):448-459 [PMID: 32175700]
  14. Oncogene. 2007 May 14;26(22):3227-39 [PMID: 17496918]
  15. Horm Metab Res. 2008 Oct;40(10):679-84 [PMID: 18537080]
  16. Circulation. 2021 Jan 26;143(4):354-371 [PMID: 33207953]
  17. J Clin Invest. 2008 Jul;118(7):2372-9 [PMID: 18596905]
  18. Biochim Biophys Acta Mol Basis Dis. 2019 Jul 1;1865(7):1810-1821 [PMID: 31109451]
  19. Circ Res. 2001 Dec 7;89(12):1147-54 [PMID: 11739279]
  20. Circulation. 2020 Nov 24;142(21):2045-2059 [PMID: 32674599]
  21. Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1837-43 [PMID: 23744991]
  22. Hypertension. 2016 Sep;68(3):796-808 [PMID: 27402919]
  23. Biol Res. 2019 Dec 4;52(1):59 [PMID: 31801629]
  24. Cell Mol Life Sci. 2007 Mar;64(6):692-703 [PMID: 17380310]
  25. Circ Res. 2011 Sep 30;109(8):880-93 [PMID: 21852550]
  26. Cancers (Basel). 2020 Aug 04;12(8): [PMID: 32759784]
  27. Mol Cell Endocrinol. 2019 Dec 1;498:110543 [PMID: 31421164]
  28. Clin Chem Lab Med. 2012 Jan 13;50(4):601-15 [PMID: 22505556]
  29. Eur J Pharmacol. 2019 Sep 15;859:172546 [PMID: 31319068]
  30. Nat Med. 2019 Aug;25(8):1280-1289 [PMID: 31359001]
  31. Nat Commun. 2018 Nov 1;9(1):4567 [PMID: 30385745]
  32. Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):302-316 [PMID: 33028096]
  33. Atherosclerosis. 2017 Nov;266:8-15 [PMID: 28946038]
  34. J Clin Endocrinol Metab. 2011 Jan;96(1):220-8 [PMID: 20962025]
  35. Cell Metab. 2014 May 6;19(5):810-20 [PMID: 24709624]
  36. Vascul Pharmacol. 2023 Oct;152:107209 [PMID: 37591444]
  37. Vascul Pharmacol. 2018 Dec;111:15-21 [PMID: 30227233]
  38. Circulation. 2009 Sep 29;120(13):1231-40 [PMID: 19752325]
  39. Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1477-1485 [PMID: 24876352]
  40. J Endocrinol. 2003 Aug;178(2):319-29 [PMID: 12904179]
  41. Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13531-6 [PMID: 14581613]
  42. Circulation. 2001 Aug 14;104(7):790-5 [PMID: 11502704]
  43. BMJ. 2020 Oct 7;371:m3502 [PMID: 33028606]
  44. Circ Res. 2008 Jun 20;102(12):1548-57 [PMID: 18483411]
  45. J Surg Res. 2009 Jul;155(1):48-53 [PMID: 19041098]
  46. Mol Cell Biol. 1993 Dec;13(12):7813-25 [PMID: 8246996]
  47. Circulation. 2020 Nov 24;142(21):2060-2075 [PMID: 32962412]
  48. Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):613-22 [PMID: 22223731]
  49. Arterioscler Thromb Vasc Biol. 2021 Nov;41(11):2693-2707 [PMID: 34470477]
  50. JAMA. 2002 Jul 17;288(3):321-33 [PMID: 12117397]
  51. Int J Mol Med. 2014 Mar;33(3):550-8 [PMID: 24398697]
  52. J Mol Cell Cardiol. 2014 Sep;74:240-50 [PMID: 24927876]
  53. Arterioscler Thromb Vasc Biol. 2003 Mar 1;23(3):489-94 [PMID: 12615658]
  54. J Biol Chem. 2020 Nov 27;295(48):16314-16327 [PMID: 32963108]
  55. Clin Sci (Lond). 2000 Jul;99(1):77-82 [PMID: 10887060]
  56. Circ Res. 2017 Jan 20;120(2):296-311 [PMID: 27834190]
  57. J Cardiovasc Pharmacol. 2011 Apr;57(4):376-9 [PMID: 21297493]
  58. Eur Respir J. 2009 Nov;34(5):1093-9 [PMID: 19357154]
  59. Physiol Rev. 2004 Jul;84(3):767-801 [PMID: 15269336]
  60. Exp Cell Res. 2017 Jan 1;350(1):73-82 [PMID: 27871850]
  61. Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1351-1368 [PMID: 31144989]
  62. JCI Insight. 2021 Oct 8;6(19): [PMID: 34622803]
  63. J Mol Endocrinol. 2019 Oct;63(3):199-213 [PMID: 31416049]
  64. Circ Res. 2009 Feb 27;104(4):476-87 [PMID: 19150885]
  65. J Biochem. 2008 Sep;144(3):313-21 [PMID: 18511453]
  66. J Vasc Surg. 2018 May;67(5):1556-1570.e9 [PMID: 28647196]
  67. Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1627-32 [PMID: 12855485]
  68. Circ Res. 2016 Feb 19;118(4):692-702 [PMID: 26892967]
  69. Vascul Pharmacol. 2016 Sep;84:8-14 [PMID: 27260939]
  70. Biochem Pharmacol. 2022 Aug;202:115117 [PMID: 35671788]
  71. Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1506-12 [PMID: 20631350]
  72. Hypertension. 2012 Jun;59(6):1263-71 [PMID: 22566500]
  73. J Biol Chem. 2008 Feb 15;283(7):3877-88 [PMID: 18042551]
  74. Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2909-19 [PMID: 21940949]
  75. Cell Rep. 2018 Apr 24;23(4):1152-1165 [PMID: 29694892]
  76. Clin Chim Acta. 2007 Jul;382(1-2):100-5 [PMID: 17493601]
  77. Eur J Pharmacol. 2017 Mar 15;799:188-195 [PMID: 28213288]
  78. Cell Signal. 2018 Dec;52:48-64 [PMID: 30172025]
  79. J Am Heart Assoc. 2022 Nov;11(21):e026953 [PMID: 36285783]
  80. Age (Dordr). 2016 Jun;38(3):60 [PMID: 27206970]
  81. Best Pract Res Clin Endocrinol Metab. 2022 Jul;36(4):101665 [PMID: 35595638]
  82. Can J Cardiol. 2010 Mar;26 Suppl A:22A-26A [PMID: 20386756]
  83. Circ Res. 2004 Nov 12;95(10):981-8 [PMID: 15486317]
  84. Circ Res. 2015 Oct 9;117(9):770-8 [PMID: 26316608]
  85. Circ Res. 2019 Feb 15;124(4):498-510 [PMID: 30582454]
  86. J Cardiovasc Pharmacol. 2005 Jun;45(6):580-5 [PMID: 15897786]
  87. Atherosclerosis. 1998 Sep;140(1):97-104 [PMID: 9733220]
  88. J Clin Invest. 2004 May;113(9):1258-65 [PMID: 15124016]
  89. J Am Heart Assoc. 2021 Apr 6;10(7):e018536 [PMID: 33719500]
  90. J Vasc Surg. 2015 Mar;61(3):767-76 [PMID: 24439319]
  91. J Clin Invest. 2006 Jan;116(1):36-48 [PMID: 16395403]
  92. Dev Biol. 1998 Jan 15;193(2):169-81 [PMID: 9473322]
  93. Int J Mol Sci. 2022 Jan 11;23(2): [PMID: 35054966]
  94. Atherosclerosis. 1997 Nov;135(1):19-27 [PMID: 9395269]
  95. Eur J Pharmacol. 2008 Sep 28;593(1-3):87-91 [PMID: 18662681]
  96. Circulation. 2014 Apr 15;129(15):1551-9 [PMID: 24481950]
  97. Atherosclerosis. 2015 Feb;238(2):220-30 [PMID: 25528431]
  98. Front Physiol. 2012 Apr 10;3:89 [PMID: 22514541]
  99. Front Cardiovasc Med. 2021 Sep 10;8:719058 [PMID: 34568460]
  100. Circulation. 2002 Jun 4;105(22):2653-9 [PMID: 12045172]
  101. Neth Heart J. 2007;15(3):100-8 [PMID: 17612668]
  102. J Vasc Surg. 2018 Jan;67(1):2-77.e2 [PMID: 29268916]
  103. Biochem Soc Trans. 1997 Feb;25(1):40-5 [PMID: 9056840]
  104. Biol Sex Differ. 2012 Feb 20;3(1):6 [PMID: 22348410]
  105. J Vasc Surg. 2016 Jun;63(6):1602-1612.e2 [PMID: 26817611]
  106. Arterioscler Thromb Vasc Biol. 2008 Aug;28(8):1505-10 [PMID: 18451334]
  107. Circ Res. 2006 Sep 1;99(5):477-84 [PMID: 16873715]
  108. Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1251-6 [PMID: 18451329]
  109. Circ Res. 2006 Aug 4;99(3):266-74 [PMID: 16794187]
  110. PLoS One. 2012;7(3):e32364 [PMID: 22396760]
  111. Pharmacol Ther. 2010 May;126(2):186-99 [PMID: 20206649]
  112. Sci Rep. 2016 Apr 20;6:24807 [PMID: 27095121]
  113. Arterioscler Thromb Vasc Biol. 2015 Nov;35(11):2384-90 [PMID: 26404484]
  114. Adv Exp Med Biol. 2018;1065:511-528 [PMID: 30051404]
  115. Front Endocrinol (Lausanne). 2021 Oct 13;12:726107 [PMID: 34721292]
  116. Sci Rep. 2017 Jun 14;7(1):3549 [PMID: 28615727]
  117. Cardiovasc Res. 2021 Apr 23;117(5):1402-1416 [PMID: 32678909]
  118. Int J Cardiol. 2009 May 29;134(3):356-65 [PMID: 18584900]
  119. Am J Respir Crit Care Med. 2015 Mar 15;191(6):693-703 [PMID: 25608111]
  120. Life Sci. 2020 Feb 1;242:117207 [PMID: 31863777]
  121. Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):585-600 [PMID: 33327741]
  122. Nat Metab. 2021 Apr;3(4):485-495 [PMID: 33846638]
  123. J Cardiovasc Transl Res. 2020 Oct;13(5):744-757 [PMID: 32072564]
  124. J Mol Cell Cardiol. 2015 Jun;83:112-21 [PMID: 25896391]
  125. Cell Rep. 2014 Mar 13;6(5):809-17 [PMID: 24582963]
  126. Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9349-54 [PMID: 18591670]
  127. Biomed Chromatogr. 2021 Jan;35(1):e5036 [PMID: 33226656]
  128. Front Immunol. 2020 Nov 26;11:599415 [PMID: 33324416]
  129. JCI Insight. 2021 Mar 22;6(6): [PMID: 33591958]
  130. J Pharmacol Exp Ther. 2010 Apr;333(1):34-42 [PMID: 20089806]
  131. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015 Jun;31(6):775-8 [PMID: 26062420]
  132. Tissue Eng Part A. 2015 Jan;21(1-2):115-23 [PMID: 24980654]
  133. Clin Chem Lab Med. 2007;45(3):321-7 [PMID: 17378726]
  134. Sci Transl Med. 2015 Oct 7;7(308):308ra159 [PMID: 26446956]
  135. Vascul Pharmacol. 2020 Jul;130:106681 [PMID: 32387336]
  136. Endocrinol Metab Clin North Am. 2015 Sep;44(3):485-96 [PMID: 26316238]
  137. Pulm Circ. 2013 Sep;3(3):564-77 [PMID: 24618541]
  138. Hypertension. 2010 Sep;56(3):453-62 [PMID: 20696983]
  139. Cell Biol Int. 2017 Jul;41(7):739-748 [PMID: 28328152]
  140. Circ Res. 2021 Jan 8;128(1):133-135 [PMID: 33146591]
  141. Biochim Biophys Acta Mol Basis Dis. 2020 Jan 1;1866(1):165587 [PMID: 31678158]
  142. Cell. 2002 Jan 11;108(1):17-29 [PMID: 11792318]
  143. Mediators Inflamm. 2020 Aug 07;2020:6850187 [PMID: 32831637]
  144. Cell Stem Cell. 2016 Nov 3;19(5):628-642 [PMID: 27618218]
  145. Circ Res. 2009 Mar 27;104(6):733-41 [PMID: 19197075]
  146. Mol Ther Nucleic Acids. 2019 Dec 6;18:999-1008 [PMID: 31778958]
  147. Am J Pathol. 1996 Mar;148(3):969-76 [PMID: 8774151]
  148. Am J Physiol Heart Circ Physiol. 2017 Sep 1;313(3):H641-H649 [PMID: 28667053]
  149. Am J Physiol. 1997 Apr;272(4 Pt 2):H1996-2003 [PMID: 9139988]
  150. Curr Osteoporos Rep. 2019 Jun;17(3):129-137 [PMID: 30949840]
  151. Menopause. 2014 Jun;21(6):661-8 [PMID: 24848355]
  152. Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):2195-2211 [PMID: 32698686]
  153. PLoS One. 2011;6(9):e25335 [PMID: 21966501]
  154. Eur J Pharmacol. 2014 Jan 15;723:131-40 [PMID: 24262995]
  155. Int J Mol Sci. 2019 Mar 05;20(5): [PMID: 30841577]
  156. Biomed Rep. 2016 Feb;4(2):197-202 [PMID: 26893838]
  157. Circulation. 2012 Aug 28;126(9):1087-98 [PMID: 22859684]
  158. Cell Stem Cell. 2020 Jan 2;26(1):81-96.e4 [PMID: 31883835]
  159. Am J Physiol Cell Physiol. 2018 May 1;314(5):C554-C568 [PMID: 29365274]
  160. Nature. 2009 Aug 6;460(7256):705-10 [PMID: 19578358]
  161. Cardiovasc Res. 2018 Mar 15;114(4):529-539 [PMID: 29394331]
  162. Curr Opin Cardiol. 1994 Sep;9(5):619-26 [PMID: 7987043]
  163. Cardiovasc Diabetol. 2016 Nov 10;15(1):156 [PMID: 27832775]
  164. Neuroendocrinology. 2008;88(3):216-26 [PMID: 18535365]
  165. J Am Heart Assoc. 2021 Apr 6;10(7):e019310 [PMID: 33719502]
  166. J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):81-9 [PMID: 18261897]
  167. Clin Chest Med. 2021 Mar;42(1):217-228 [PMID: 33541615]
  168. Circ Res. 2014 Sep 12;115(7):662-7 [PMID: 25070003]
  169. JCI Insight. 2020 Dec 3;5(23): [PMID: 33119549]
  170. J Vasc Surg. 2007 Jun;45 Suppl A:A25-32 [PMID: 17544021]
  171. Eur J Clin Invest. 2023 Jan;53(1):e13885 [PMID: 36219492]
  172. PLoS One. 2015 Sep 30;10(9):e0139608 [PMID: 26422690]
  173. Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4065-70 [PMID: 17360478]
  174. Arterioscler Thromb Vasc Biol. 2011 Jun;31(6):1387-96 [PMID: 21454810]
  175. Int J Mol Med. 2015 May;35(5):1460-6 [PMID: 25777140]
  176. Br J Pharmacol. 2012 Feb;165(3):643-58 [PMID: 21470202]
  177. J Stroke Cerebrovasc Dis. 2021 Dec;30(12):106033 [PMID: 34598837]
  178. Cardiovasc Res. 2018 Mar 15;114(4):590-600 [PMID: 29514202]
  179. J Biophotonics. 2021 Jan;14(1):e202000329 [PMID: 32888351]
  180. Circ Res. 2001 Dec 7;89(12):1111-21 [PMID: 11739275]
  181. Circ Res. 2021 Nov 12;129(11):992-1005 [PMID: 34615369]
  182. Vascular. 2020 Aug;28(4):465-474 [PMID: 32089109]
  183. Am J Surg. 2009 Jan;197(1):49-54 [PMID: 18585678]
  184. Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2370-7 [PMID: 22011749]
  185. N Engl J Med. 1999 Jun 10;340(23):1801-11 [PMID: 10362825]
  186. J Surg Res. 2013 Oct;184(2):1182-95 [PMID: 23632004]
  187. Am J Physiol Cell Physiol. 2009 Nov;297(5):C1178-87 [PMID: 19741198]
  188. Ann Transl Med. 2020 Jun;8(12):762 [PMID: 32647687]
  189. Onco Targets Ther. 2016 Jun 07;9:3415-22 [PMID: 27354813]
  190. Pharmacol Ther. 2014 Sep;143(3):265-74 [PMID: 24657708]
  191. Onco Targets Ther. 2020 May 06;13:3801-3808 [PMID: 32440148]
  192. Biol Sex Differ. 2024 Jan 23;15(1):9 [PMID: 38263051]
  193. J Biol Chem. 2010 Mar 5;285(10):7537-44 [PMID: 20048160]
  194. Biochem J. 2004 Jun 1;380(Pt 2):297-309 [PMID: 15005655]
  195. Cell Stem Cell. 2020 Apr 2;26(4):542-557.e11 [PMID: 32243809]
  196. Curr Opin Lipidol. 2013 Jun;24(3):214-20 [PMID: 23594711]
  197. Arterioscler Thromb Vasc Biol. 2019 May;39(5):876-887 [PMID: 30786740]
  198. Bioengineering (Basel). 2020 Aug 06;7(3): [PMID: 32781528]
  199. Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H1798-809 [PMID: 21890685]
  200. Cell Mol Life Sci. 2019 Jun;76(11):2077-2091 [PMID: 30887097]
  201. Int J Mol Sci. 2019 Jun 01;20(11): [PMID: 31159449]
  202. J Clin Endocrinol Metab. 1999 Nov;84(11):4025-30 [PMID: 10566644]
  203. Nat Med. 2015 Jun;21(6):628-37 [PMID: 25985364]
  204. J Clin Invest. 2021 Mar 15;131(6): [PMID: 33497359]
  205. Oncotarget. 2017 Nov 10;8(66):110039-110051 [PMID: 29299128]

Grants

  1. U23A20398, 82030007/National Natural Science Foundation of China
  2. 82301845/National Natural Science Foundation of China
  3. 2023M732929/China Postdoctoral Science Foundation

MeSH Term

Humans
Muscle, Smooth, Vascular
Gonadal Steroid Hormones
Myocytes, Smooth Muscle
Animals
Phenotype
Signal Transduction

Chemicals

Gonadal Steroid Hormones

Word Cloud

Created with Highcharts 10.0.0hormonesvascularVSMCssexphenotypicsmoothmusclecellsdiseasesSexbiologicalfunctioninfluencehumanbodyswitchingplaypivotalroleendocrineexertprofoundeffectscharacteristicsmodulatingintracellularsignalingpathwaysactivatingnuclearreceptorsregulatinggeneexpressionintricatelymorphologyphysiologicalstatetherebyimpactingpropertiescontractionrelaxationgrowthIncreasingevidencesuggestsabnormalchangescontributeinitiationincludingatherosclerosisThereforeunderstandingfactorsgoverningalterationselucidatingunderlyingmechanismscanprovidecrucialinsightsrefininginterventionstargetedAdditionallyvaryinglevelsdifferenttypesinfluencedagemayalsoaffectconversionreviewaimsexploredevelopmentassociatedHormonalinfluence:unravelingimpactDiseasesPhenotypicVascular

Similar Articles

Cited By

No available data.